330 articles in this topic
New research reveals E. coli dominates and suppresses S. aureus in dual-species implant biofilms, with major implications for treating polymicrobial joint infections.
JAMA publishes a timely review of IgA nephropathy, the leading cause of primary glomerulonephritis worldwide, amid a wave of new therapies.
Nephrologists from Canada and Ireland address clinical questions on IgA nephropathy, one of the most common causes of kidney failure worldwide.
Scientists are monitoring an unusual hantavirus case aboard a cruise ship, raising questions about transmission risks in confined travel settings.
A comprehensive StatPearls review covering every drug class used to treat childhood asthma, from inhalers to cutting-edge biologics.
A new oligonucleotide probe workflow recovers complete RSV and norovirus genomes from low-titer clinical samples, transforming viral surveillance.
A randomized trial shows prophylactic obinutuzumab dramatically reduces steroid-requiring cGVHD after bone marrow transplant.
A mechanistic deep-dive into cutting-edge anti-inflammaging interventions — from senolytic pharmacology and precision cytokine targeting to partial reprogramming strategies that aim to restore youthful immune homeostasis.
Go beyond inflammaging basics to understand how aging reshapes immune cell populations, triggers the SASP, and locks the body into a state of chronic low-grade inflammation at the molecular level.
Scientists reveal how a measles antiviral also blocks Nipah virus and use structural insights to engineer more potent next-generation inhibitors.
A phase 1/2 trial finds low-dose oral NMN safely raises platelet counts in steroid-refractory ITP via a novel immunometabolic mechanism.
Early influenza infections leave a lasting immunological imprint that determines how your immune system responds to entirely different flu strains later in life.
